Latest Breaking News On - Merz pharmaceuticals frankfurt - Page 1 : comparemela.com

EQS-News: iOmx Therapeutics AG / Key word(s): PersonneliOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CESTThe issuer is solely responsible for the content of this announcement.iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business OfficerMartinsried / Muni.

New zealand generalNew zealandUnited statesNils debusApollon papadimitriouNils peter debusKatja arnoldBoehringer ingelheimShaun brownAthos biopharmaMerz pharmaceuticals frankfurtDuke university durhamGerman cancer research centerHumboldt university berlinMc servicesBusiness development licensing